M&A Deal Summary

PositiveID Acquires Easy Check Medical Diagnostics

On February 17, 2010, PositiveID acquired medical products company Easy Check Medical Diagnostics

Acquisition Highlights
  • This is PositiveID’s 1st transaction in the Medical Products sector.
  • This is PositiveID’s 1st transaction in the United States.
  • This is PositiveID’s 1st transaction in Florida.

M&A Deal Summary
Date 2010-02-17
Target Easy Check Medical Diagnostics
Sector Medical Products
Buyer(s) PositiveID
Deal Type Add-on Acquisition

Target

Easy Check Medical Diagnostics

Miami, Florida, United States
Easy Check Medical Diagnostics LLC is a non-invasive glucose detection system that measures acetone levels in a patient's exhaled breath. Easy Check's breath glucose detection system combines a proprietary chemical mixture of natrium nitroprussid with breath exhalate, which is intended to create a new molecular compound that can be measured with its patent pending technology.

Search 193,240 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

PositiveID

Delray Beach, Florida, United States

website

Category Company
Sector Life Science
Revenue 5M USD (2017)
DESCRIPTION

PositiveID is a life sciences tools and diagnostics company with an extensive patent portfolio. PositiveID develops biological detection and diagnostics systems, specializing in the development of microfluidic systems for the automated preparation of and performance of biological assays. PositiveID is based in Delray Beach, Florida.

DEAL STATS #
Overall 1 of 4
Sector (Medical Products) 1 of 2
Type (Add-on Acquisition) 1 of 4
State (Florida) 1 of 2
Country (United States) 1 of 4
Year (2010) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2008-05-19 Xmark

Ottawa, Ontario, Canada

Xmark markets and sells RFID-based systems used to identify, locate and protect people and assets.

Sell $45M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2011-05-10 MicroFluidic Systems

Pleasanton, California, United States

MicroFluidic Systems is focused on the development of microfluidic systems for automated preparation of and performance of biological assays. MFSI personnel have been involved with the development of automated DNA-based pathogen detection systems and microfluidics for the U.S. Government and commercial markets for over 25 years, including the world's first miniaturized, portable, battery-operated, real-time, PCR-based detection system.

Buy $8M
Mergr

Product

Company

Legal